NorthEast BioLab, has 15+ years of experience in quantitation of drug, metabolites, and biomarkers, as well as clinical trial kitting and biosample storage. Our mission-driven team of veteran scientists has an excellent track record of providing rapid and high-quality drug discovery, GLP, and clinical bioanalytical services. We have completed 500+ preclinical and clinical studies, and our data has been included in several IND/ NDA filings. We have built our reputation as a service-based small business partnering with some of the top biotech and pharma companies, as well as research groups in academic labs at Brown, Dana Farber, Columbia, Duke, MD Anderson, Sarah Cannon, Sloan Kettering, Moffitt, UChicago, and UCSF, and Yale. We are a fully GLP and GCP compliant, FDA audited, DEA Schedule II-V approved bioanalytical laboratory.
We are an ambitious group of healthcare investors, and scientists brought together by our shared passion for high-quality and innovative drug development and research. In our quest to facilitate superior treatments, we learned that it takes deep-rooted partnerships within the scientific community to develop and commercialize medicines for life-threatening diseases. Driven by this principle, we founded North East Bioanalytical Laboratories (NorthEast BioLab) – a boutique clinical research organization (CRO) – in 2003. Henceforth, we have been focused on providing tailor-made research and development solutions to biotech and pharma companies.
Our bioanalysis lab facility is in New Haven, CT. We are an entrepreneurial and mission-driven CRO aiming to realize the full potential of our dedicated scientists and analytical chemists. Over the years, we have established ourselves as a full-service, boutique CRO lab specializing in small and large molecule bioanalysis of pharmaceutical, generics, biologics, and vaccines in discovery and development stages. We seek fulfillment in providing clients with hands-on flexibility and versatility with excellent standards of quality service for each project. High quality plays an instrumental role in drug development programs – especially as our clients are usually looking to expedite drug discovery and development at lower costs.
Long-Standing History of Providing Custom CRO Lab Services
NorthEast Biolab has a successful history as an independent CRO Lab services provider in the consolidating world of outsourced pharmaceutical research and drug development. We have remarkable experience in PK sample analysis and TK safety testing using mass spectrometric and chromatographic bioanalytics. Other bioanalytical CRO lab capabilities include biomarker testing, cell-based assay, cytotoxicity assay, immunogenicity testing, biochemical assay, and Mechanism of Action (MoA) studies. Over the years, we have supported an increasing number of Investigational New Drug (IND), New Drug Application (NDA), Generics Application (ANDA), and Biologic License Application (BLA).
We are continually exploring exciting opportunities for new research projects, preclinical studies, and clinical trials. Our core objective is to provide high-quality, actionable data within the quoted budget and promised timelines. We optimize the combined expertise of our veteran and your in-house scientific team to bring success to our partner pharma and biotech companies. Our decades of acquired experience and applied knowledge can help you forge seamless operations. As a leading CRO pharma company, we deliver accurate results for your processes time and again. It is a partnership, thriving on trust, and transparency.
To that end, we have established integrity, respect, excellence, and transparency as the cornerstones of our organization. Thus, you can trust our expert team of seasoned professionals and accomplished scientists to deliver accurate results. Our CRO biotech team leverages its bioanalytical expertise to handle your preclinical studies and clinical trials successfully. Furthermore, we are open to and thoroughly enjoy the partnerships that we build with other CRO companies to support your drug research and development.
Join Our Diverse Client Base of Top Biotech and Pharmaceutical Companies
We have primarily been able to maintain a thriving CRO company due to our diverse client base. From emerging biotech to top pharma companies, we serve the full spectrum of the industry with our drug discovery and development solutions. Furthermore, we appreciate broadening our horizons to welcome an even wider variety of clients to our expanding team, including several personal care and food testing companies. We take on each of your study as a passion project where our scientists and expert team members strive to achieve the best possible outcome for you.
We, at NorthEast BioLab, take pride in the fact that the diversity of our client base matches the diversity of our staff. Our team consists of industry leaders and subject matter experts within the field of pharmaceutical/biotech R&D and bioanalysis. We enjoy bringing the very best combination and collaboration of scientific, operational, and clinical experience to each project. We understand that it takes considerable time, effort, and resources to initiate, manage, monitor, and complete drug development studies successfully. Therefore, our CRO lab team of experts will put our decades of collective experience and expertise to work for you. You can rest assured that we will enthusiastically commit our time, energy, effort, and resources towards your program.
Contact us so we can determine the business fit and discuss our partnership. From our end, we will focus on how our team here at NorthEast Biolab can help you and your organization.